Health Startup Noom Adding GLP-1 Drugs to Med Plan Now
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
Find out which credit cards offer free travel benefits to save money on your next adventure. Explore your options now!
25,088 articlesNoom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
Two frontier AI firms are tipped for 2026 IPOs, with lofty valuations and aggressive monetization bets, as markets we...
Oil prices jump amid Iran tensions, lifting fuel costs for cruise lines. Analysts warn Carnival could bear a sizable ...
A Trump-era regulatory push aims to bring major crypto firms into the federal banking system, signaling a potential o...
The 2025 ATTOM report shows a sharp slowdown in home flipping activity, with profits slipping to pre-crisis levels as...
Reddit plans a major expansion of its new-grad hiring, arguing AI-native graduates can accelerate product development...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
ARTY leads humanoid-robot ETFs in 2026, outpacing BOTT and ROBO as investors chase AI software momentum. This shift h...
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Vanguard’s VTSAX has posted roughly a 300% gain over the last ten years, outpacing most active funds amid a tech-driv...
Vanguard's VTWO and iShares' IWM both mirror the Russell 2000, but over 10 years VTWO's return outpaces IWM by roughl...
Iren has closed a $3 billion convertible notes sale at a 1% coupon, due 2033, to bankroll its AI cloud infrastructure...